Gianna Melillo

Camillo Ricordi, MD, FNAI, describes the process of islet transplantation and how it can benefit individuals with type 1 diabetes.

Catlin Dennis, MPH, describes her research on the impacts of COVID-19 on Oregon’s most medically and socially vulnerable youth with diabetes.

Leslie Eiland, MD, discusses the benefits of remote monitoring among patients with type 1 diabetes (T1D) living in rural America.

Bobeck Modjtahedi, MD, describes how Kaiser Permanente leveraged its telehealth resources to provide care to those with diabetic retinopathy (DR) throughout the COVID-19 pandemic.

Michelle Litchman, PHD, FNP-BC, FAANP, FADCES, an assistant professor at the College of Nursing at the University of Utah, highlights her research on the benefits of concurrent continuous glucose monitoring and online peer support groups for Spanish-speaking patients with diabetes.

Aleksandar Kostic, PhD, an assistant professor of microbiology at Harvard Medical School, describes the research linking gut microbiota and incidence of type 1 diabetes.

Ezio Bonifacio, PhD, discusses the optimal time to begin monitoring for type 1 diabetes (T1D) in children genetically at risk for the disease.

Ann Goebel-Fabbri, PhD, a clinical psychologist in Boston, Massachusettes, outlines trends in eating disorders among patients with type 1 diabetes.

Mary Pat Gallagher, MD, of NYU Langone Health, explains her research documenting new onset diabetes and diabetic ketoacidosis (DKA) throughout the COVID-19 pandemic.

David McIntyre, MD, FRACP, gives an overview of his talk "Diagnosis and Management of Diabetes in Pregnancy During the COVID-19 Pandemic," to be presented at the American Diabetes Association's (ADA) 81st Scientific Sessions.

Research presented at the American Headache Society's 63rd Annual Scientific Meeting outlines the association between migraine and history of mild traumatic brain injury.

New CMS changes aim to broaden coverage of continuous glucose monitoring (CGM) devices.

Stephanie Lovinsky-Desir, MD, MS, discusses the need for concrete changes addressing social determinants of health (SDOH) and respiratory health.

Study results indicate COVID-19 transmission mitigation efforts may have led to delayed diagnoses of type 1 diabetes (T1D) in Finnish children, resulting in more cases of diabetic ketoacidosis at presentation.

National Institutes of Health–sponsored research examines the underlying cause of COVID-19–induced diabetes.

Fernando Holguin, MD, explains why increased risk of pulmonary disease may be overlooked when assessing obesity risk factors.

Study results show that those with migraine are more likely to develop rheumatoid arthritis (RA) and those with RA are also more likely to have migraine.

A roundup of technology-related research presented at SLEEP 2021.

Experts discuss their research on the impact of sex differences in alcohol use disorder (AUD)-related sleep health.

Results of a post-hoc analysis underscore the efficacy of the Idiopathic Hypersomnia Severity Scale to measure symptoms of idiopathic hypersomia.

Several studies presented at SLEEP 2021 highlight the negative impact COVID-19 has had on youth sleep health.

Research presented at SLEEP 2021 underscores the important role of sleep for firefighters, soldiers, and flight crew members.

A session presented at Virtual SLEEP 2021 highlights the social and environmental factors that impact sleep health.

Abstracts presented at SLEEP 2021 include real-world data characterizing individuals with central disorders of hypersomnolence.

Results of a systematic review and meta-analysis point to higher rates of metabolic syndrome among patients with psoriatic arthritis.

Using the new data initiative, researchers hope to diagnose unsolved cases of rare diseases.

New FDA guidance includes updates for assessing patient-reported outcomes in cancer trials.

Results of a systematic review underscore implications of increased rates of metabolic syndrome among youth with type 1 diabetes.

Results of a nationwide study show earlier onset of type 1 diabetes (T1D) is associated with worse glycemic outcomes and presence of albuminuria.

Almost half of US migraineurs hesitate to seek out care for their condition, according to research presented at the American Headache Society's 63rd Annual Scientific Meeting.